Researchers led by the University of Bath have developed a sunlight-activated catalyst capable of breaking down persistent “forever chemicals” in water. Reported in RSC Advances, the carbon-based photocatalyst targets PFAS and converts them into less harmful substances under neutral environmental conditions.

Researchers at the University of Pennsylvania have discovered a way to make mRNA vaccines safer and more effective — by adding anti-inflammatory molecules inspired by olive oil. Their new lipid design not only reduces side effects like soreness and fatigue but also boosts vaccine performance against diseases like Covid-19 and cancer.

A new algae-based biochar material could offer a breakthrough in tackling PFAS pollution. Researchers report that a photocatalytic nanoreactor made from marine algae removes more than 97 percent of the toxic “forever chemical” PFOA from water, combining high efficiency, reusability, and easy recovery with a sustainable biomass-based design.

In a new study, researchers have integrated data from all three types of genetic testing to create a 360-degree view of disease risk. Their approach identifies rare mutations, evaluates cumulative genetic influences and uncovers hidden patterns in the full genome.

A chemistry breakthrough has been achieved by chemists wherein they can make substitutes of the Tamoxifen drug which is used to prevent breast cancer in women and men. The new drug alternatives have the potential to be more effective and also have less side effects.

Children, older adults and people who spend most of their time indoors may face elevated health risks from unseen household contaminants. Researchers now warn that modern buildings can trap and transform chemicals in ways that amplify long-term exposure.

Researchers have recently tested a Crispr/Cas9 gene-editing technique to help the immune system in a person’s body to fight advanced gastrointestinal cancers. The results have revealed promising signs of safety and potential effectiveness of the treatment.

Modern laboratory diagnostics is the first step toward successful patient treatment. During the MEDICA LABMED FORUM from November 17 to 20, experts will discuss what will shape laboratory medicine in the coming years.

With a massive investment of 2 billion dollars, Astrazeneca has plans to expand its manufacturing footprint in Maryland, USA. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supply of innovative molecules to be used in clinical trials.

Researchers from the USA are spearheading a project to test whether reducing DNA-triggered inflammation can help older adults stay healthier for longer. The federal Advanced Research Projects Agency for Health has also awarded 22 million dollars to the project.